139 related articles for article (PubMed ID: 6777812)
1. Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthate.
Wiles D; Franklin M; Dencker SJ; Johansson R; Lundin L; Malm U
Psychopharmacology (Berl); 1980; 71(2):131-6. PubMed ID: 6777812
[TBL] [Abstract][Full Text] [Related]
2. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
Wiles DH; Gelder MG
Br J Clin Pharmacol; 1979 Dec; 8(6):565-70. PubMed ID: 533577
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of fluphenazine and prolactin in psychiatric patients.
Kitamura T; McGovern DA; Imlah NW; Wiles D; Schiff AA
Eur Arch Psychiatry Neurol Sci; 1988 Sep; 237(6):320-6. PubMed ID: 3181218
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia.
Chang SS; Javaid JI; Dysken MW; Casper RC; Janicak PG; Davis JM
Psychopharmacology (Berl); 1985; 87(1):55-8. PubMed ID: 3933037
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
Wiles DH; McCreadie RG; Whitehead A
Psychopharmacology (Berl); 1990; 101(2):274-81. PubMed ID: 2349370
[TBL] [Abstract][Full Text] [Related]
6. Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients.
Altamura AC; Curry SH; Montgomery S; Wiles DH
Psychopharmacology (Berl); 1985; 87(1):30-3. PubMed ID: 3933035
[TBL] [Abstract][Full Text] [Related]
7. Prolactin bioassay in schizophrenia before and after neuroleptics.
Peabody CA; Warner MD; Griffin M; Boutros NN; Worsley IG; Friesen HG
Psychiatry Res; 1992 Mar; 41(3):249-55. PubMed ID: 1594711
[TBL] [Abstract][Full Text] [Related]
8. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
Wiles DH; Gelder MG
Adv Biochem Psychopharmacol; 1980; 24():599-602. PubMed ID: 7405678
[No Abstract] [Full Text] [Related]
9. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
[TBL] [Abstract][Full Text] [Related]
11. Effects of perphenazine enanthate injections on prolactin levels in plasma from schizophrenic women and men.
Lindholm H; Gullberg B; Ohman A; Sedvall G
Psychopharmacology (Berl); 1978 Apr; 57(1):1-4. PubMed ID: 96459
[TBL] [Abstract][Full Text] [Related]
12. Serum and cerebrospinal fluid prolactin patterns during neuroleptic treatment in schizophrenic patients.
Rimón R; Kampman R; Laru-Sompa R; Heikkilä L
Pharmacopsychiatry; 1985 May; 18(3):252-4. PubMed ID: 4011674
[TBL] [Abstract][Full Text] [Related]
13. Depot fluphenazine and plasma prolactin.
Gift T; Plum K; Price M
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):407-12. PubMed ID: 4070643
[TBL] [Abstract][Full Text] [Related]
14. The determination of the steady-state pharmacokinetic profile of fluphenazine decanoate by gas chromatography/mass spectrometry detection.
Glazer WM; Friedhoff LT; Marder SR; Brown WA
Schizophr Res; 1992 Dec; 8(2):111-7. PubMed ID: 1457388
[TBL] [Abstract][Full Text] [Related]
15. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
Brown WA; Silver MA
J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
[TBL] [Abstract][Full Text] [Related]
16. The effect of fluphenazine on basal prolactin concentrations.
Chalmers RJ; Bennie EH
Psychol Med; 1978 Aug; 8(3):483-6. PubMed ID: 704714
[TBL] [Abstract][Full Text] [Related]
17. Plasma prolactin and fluphenazine concentrations in patients receiving fluphenazine decanoate: stability over injection intervals.
Norman TR; Marriott PF; Kimber NM; Burrows GD
Int Clin Psychopharmacol; 1987 Oct; 2(4):299-305. PubMed ID: 3693869
[TBL] [Abstract][Full Text] [Related]
18. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
Chouinard G; Annable L; Jones BD; Collu R
Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
[TBL] [Abstract][Full Text] [Related]
19. Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study.
Dudley J; Rauw G; Hawes EM; Keegan DL; Midha KK
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):791-5. PubMed ID: 6686710
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
McKane JP; Robinson AD; Wiles DH; McCreadie RG; Stirling GS
Br J Psychiatry; 1987 Sep; 151():333-6. PubMed ID: 3322467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
